Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 May;130(5):588-595.
doi: 10.1016/j.amjmed.2016.11.027. Epub 2016 Dec 21.

Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism

Deisy Barrios  1 , Jeremy Chavant  2 , David Jiménez  3 , Laurent Bertoletti  4 , Vladimir Rosa-Salazar  5 , Alfonso Muriel  6 , Alain Viallon  2 , Carmen Fernández-Capitán  7 , Roger D Yusen  8 , Manuel Monreal  9 ; Registro Informatizado de la Enfermedad TromboEmbólica Investigators
Collaborators, Affiliations

Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism

Deisy Barrios et al. Am J Med. 2017 May.

Erratum in

Abstract

Background: Evidence-based recommendations do not adequately address the treatment of right heart thrombi in patients who present with acute symptomatic pulmonary embolism.

Methods: This study included patients who had acute pulmonary embolism associated with right heart thrombi and participated in the Registro Informatizado de la Enfermedad TromboEmbólica registry. We assessed the effectiveness of anticoagulation versus reperfusion treatment for the outcomes of all-cause mortality, pulmonary embolism-related mortality, recurrent venous thromboembolism, and major bleeding rates through 30 days after initiation of pulmonary embolism treatment. We used propensity score matching to adjust for the likelihood of receiving reperfusion treatment.

Results: Of 325 patients with pulmonary embolism and right heart thrombi, 255 (78%; 95% confidence interval, 74-83) received anticoagulation and 70 (22%; 95% confidence interval, 17-26) also received reperfusion treatment. Propensity score-matched pairs analyses did not detect a statistically lower risk of all-cause death (6.2% vs 14%, P = .15) or pulmonary embolism-related mortality (4.7% vs 7.8%; P = .47) for reperfusion compared with anticoagulation. Of the patients who received reperfusion treatment, 6.2% had a recurrence during the study follow-up period, compared with 0% of those who received anticoagulation (P = .049). The incidence of major bleeding events was not statistically different between the 2 treatment groups (3.1% vs 3.1%; P = 1.00).

Conclusions: In patients with pulmonary embolism and right heart thrombi, no significant difference was found between reperfusion therapy and anticoagulant therapy for mortality and bleeding. The risk of recurrences was significantly higher for reperfusion therapy compared with anticoagulation. Right heart thrombi may not warrant riskier interventions than standard anticoagulation.

Keywords: Anticoagulation; Pulmonary embolism; Right heart thrombi; Thrombolysis; Treatment.

PubMed Disclaimer

Comment in

  • Free-Floating Right Heart Thrombi.
    Dalen JE. Dalen JE. Am J Med. 2017 May;130(5):501. doi: 10.1016/j.amjmed.2016.11.041. Epub 2016 Dec 22. Am J Med. 2017. PMID: 28012824 No abstract available.
  • Right Heart Thrombi Treatment.
    Özlek B, Özlek E, Yıldırım B, Biteker M. Özlek B, et al. Am J Med. 2017 Jun;130(6):e269. doi: 10.1016/j.amjmed.2017.01.028. Am J Med. 2017. PMID: 28532848 No abstract available.
  • The Reply.
    Barrios D, Monreal M, Yusen RD, Jiménez D. Barrios D, et al. Am J Med. 2017 Jun;130(6):e271. doi: 10.1016/j.amjmed.2017.02.011. Am J Med. 2017. PMID: 28532849 No abstract available.

MeSH terms

LinkOut - more resources